Table 5.
Drug combinations | Bacteria interacting with C. albicans | Effect on polymicrobial biofilm | Reference |
---|---|---|---|
Polymyxin and amphotericin B | P. aeruginosa | Combination of amphotericin B and highest concentration of polymyxin could eradicate polymicrobial biofilms | Rodrigues et al. (2017) |
Flucloxacillin, ciprofloxacin and fluconazole | S. aureus and P. aeruginosa | Combination of all three drugs was required to inhibit all three microbes in the biofilm | Townsend et al. (2017) |
Anidulafungin and tigecycline | S. aureus | Synergism against in vivo intra-abdominal biofilms | Rogiers et al. (2018) |
2-aminobenzimidazole and curcumin | S. aureus | Increased biofilm inhibition by combination | Tan et al. (2019) |
Caspofungin and polymyxin B | P. aeruginosa | Combination was able to significantly reduce the total biomass of mixed biofilms | Fernandes et al. (2020) |
Antifungal chalcone-based derivative and antibacterial polycyclic anthracene-maleimide adduct | S. aureus | Synergistic biofilm inhibition | Bonvicini et al. (2021) |
Berberine and amphotericin B | S. aureus | Synergistic biofilm inhibition with reduced hyphal formation and adhesion | Gao et al. (2021) |
Farnesol combined with myricetin, C135* and compound 1771** | S. mutans | Eliminated bacteria from dual species biofilm | Lobo et al. (2021) |
C135 and fluoride | S. mutans | Eliminated bacteria from dual species biofilm | Lobo et al. (2021) |
Bacterial biosurfactant and DNase | S. epidermidis | Synergistic activity against biofilms | Srikanth et al. (2021) |
*4-OH chalcone.
**5-phenyl-1,3,4-oxadiazol-2-yl)carbamoyl]methyl 2-{naphtho[2,1-b]furan-1-yl}acetate).